| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |